A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00460-1/fulltext?dgcid=hubspot_update_feature_updatealerts_eclinm&utm_campaign=update-eclinm&utm_medium=email&_hsmi=285633353&_hsenc=p2ANqtz--I3D3xskI8hJQiZ5OqB_eZdQMGIOP67esPf6lnKYEzRDiYfLocLavU1-y_5Fk-eItt_tk3WGqpcLuxPrvQnSUY5EpujQ&utm_content=285625883&utm_source=hs_email